Glutamate-related biomarkers in drug development for disorders of the nervous system workshop summary

Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range o...

Descripción completa

Detalles Bibliográficos
Autor Corporativo: Institute of Medicine (U.S.). Forum on Neuroscience and Nervous System Disorders (-)
Otros Autores: Pankevich, Diana E., 1975- (-), Altevogt, Bruce M., Davis, Miriam (Medical writer)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press ©2011.
Colección:National Academies ebooks.
Acceso en línea:Conectar con la versión electrónica
Ver en Universidad de Navarra:https://innopac.unav.es/record=b44928257*spi
Descripción
Sumario:Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders. Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat. Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. This book investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders. Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.
Descripción Física:1 recurso electrónico (xii, 61 páginas) : ilustraciones
Formato:Forma de acceso: World Wide Web.
Bibliografía:Incluye referencias bibliográficas (páginas 39-43).
ISBN:9780309212229
9781283213455